Antineoplastic therapy in colorectal cancer through proteasome inhibition

Hochwald, Steven N.; Lind, D. Scott; Malaty, John; Copeland III, Edward M.; Moldawer, Lyle L.; MacKay, Sally L. D.; Copeland, Edward M 3rd
January 2003
American Surgeon;Jan2003, Vol. 69 Issue 1, p15
Academic Journal
journal article
Upregulation of nuclear factor (NF)-kappaB is found in many forms of cancer. Activation of NF-kappaB in cancer cells by chemotherapy or radiation can blunt the ability of this therapy to induce cell death. Proteasome inhibitors stimulate apoptosis in part via prevention of NF-kappaB activation. We sought to determine whether constitutive NF-kappaB activity is present in human colon cancer. In addition we studied whether alterations of NF-kappaB activity with a proteasome inhibitor would prevent colon cancer cell growth and induce apoptosis. We demonstrated constitutive transcriptional activation of NF-kappaB in SW48 and SW116 colon cancer cells by luciferase and electromobility shift assays. This was confirmed by p65 immunostaining. This activity was further induced in the presence of chemotherapy. In colon cancer specimens constitutive activation of NF-kappaB was observed in the majority of tumors. Treatment with the proteasome inhibitor (MG-132) inhibited growth and also stimulated apoptosis of colon cancer cells. We conclude that inhibition of NF-kappaB activation may be a logical therapy for certain cancers. This can be done via specific approaches on molecules necessary for keeping NF-kappaB inactivated in the cytoplasm. Other potentially useful ways to promote apoptosis in cancer cells include the utilization of proteasome inhibitors. Such inhibitors are currently being evaluated in clinical trials.


Related Articles

  • Potential Targets for Colorectal Cancer Prevention. Temraz, Sally; Mukherji, Deborah; Shamseddine, Ali // International Journal of Molecular Sciences;Sep2013, Vol. 14 Issue 9, p17279 

    The step-wise development of colorectal neoplasia from adenoma to carcinoma suggests that specific interventions could delay or prevent the development of invasive cancer. Several key factors involved in colorectal cancer pathogenesis have already been identified including cyclooxygenase 2...

  • NF-κB is a critical mediator of BRCA1-induced chemoresistance. Harte, M T; Gorski, J J; Savage, K I; Purcell, J W; Barros, E M; Burn, P M; McFarlane, C; Mullan, P B; Kennedy, R D; Perkins, N D; Harkin, D P // Oncogene;2/6/2014, Vol. 33 Issue 6, p713 

    BRCA1 mediates resistance to apoptosis in response to DNA-damaging agents, causing BRCA1 wild-type tumours to be significantly more resistant to DNA damage than their mutant counterparts. In this study, we demonstrate that following treatment with the DNA-damaging agents, etoposide or...

  • Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells. Esparza-López, José; Medina-Franco, Heriberto; Escobar-Arriaga, Elizabeth; León-Rodríguez, Eucario; Zentella-Dehesa, Alejandro; Ibarra-Sánchez, María // Journal of Cancer Research & Clinical Oncology;Oct2013, Vol. 139 Issue 10, p1625 

    Purpose: NF-κB transcription factor has been associated with cancer development and chemoresistance. We studied the signaling pathway activated by doxorubicin (DOX) leading to NF-κB activation in breast cancer cells. Methods: NF-κB activity was evaluated by electrophoretic mobility...

  • MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha. Huang, Fengting; Tang, Jian; Zhuang, Xiaohong; Zhuang, Yanyan; Cheng, Wenjie; Chen, Wenbo; Yao, Herui; Zhang, Shineng // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Aberrant expression of miR-196a has been frequently reported in different cancers including pancreatic cancer. However, its function in pancreatic cancer has not been fully elucidated. Here, we investigated the expression pattern and the biological role of miR-196a in pancreatic cancer cell...

  • Colorectal cancer and NF-κB signaling pathway. Hassanzadeh, Parichehr // Gastroenterology & Hepatology from Bed to Bench;Jul2011, Vol. 4 Issue 3, p127 

    Colorectal cancer (CRC) is the second leading cause of cancer death. Progress has been made in the development of chemotherapy for advanced CRC. Targeted therapies against VEGF or EGFR are now commonly used. However, many cases show that tolerance develops to such treatments; therefore, new...

  • Nuclear Factor Kappa B, Matrix Metalloproteinase-1, p53, and Ki-67 Expressions in the Primary Tumors and the Lymph Node Metastases of Colorectal Cancer Cases. Meteoglu, Ibrahim; Erdogdu, Ibrahim Halil; Tuncyurek, Pars; Coskun, Adil; Culhaci, Nil; Erkus, Muhan; Barutca, Sabri // Gastroenterology Research & Practice;4/6/2015, Vol. 2015, p1 

    Colorectal cancer (CRC) is the third most frequent malignancy. Many factors such as NF-κB, matrix metalloproteinase-1 (MMP-1), p53, and Ki-67 are likely to be involved in its development and progression. Lymph node metastases indicate increased tumor burden and tumor cell heterogeneity and...

  • Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells. LABBOZZETTA, MANUELA; POMA, PAOLA; VIVONA, NICOLETTA; GULINO, ALESSANDRO; D'ALESSANDRO, NATALE; NOTARBARTOLO, MONICA // Oncology Letters;Dec2015, Vol. 10 Issue 6, p3807 

    Raf-1 kinase inhibitor protein (RKIP) is a tumor suppressor and metastasis inhibitor, which enhances drug-induced apoptosis of cancer cells. Downregulation of RKIP may be significant in the biology of highly aggressive and drug-resistant tumors, for example triple-negative breast cancers...

  • Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway. Wang, Tz-Ping; Hsu, Shu-Han; Feng, Hsin-Chun; Huang, Rwei-Fen S. // Carcinogenesis;Jun2012, Vol. 33 Issue 6, p1158 

    Low folate status is well recognized as one of the metabolic stressors for colorectal cancer carcinogenesis, but its role in colon cancer invasion remains unknown. Activation of the Sonic hedgehog (Shh) signal in interaction with the transcription nuclear factor-kappa B (NF-κB) pathway is...

  • Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells. Yun-feng SHAN; Xian SHEN; Yuan-kang XIE; Ji-cai CHEN; Hong-qi SHI; Zheng-ping YU; Qi-tong SONG; Men-tao ZHOU; Qi-yu ZHANG // Acta Pharmacologica Sinica;Nov2009, Vol. 30 Issue 11, p1537 

    AbstractAim:To investigate the effects and possible mechanisms of tanshinone II-A, an alcohol extract of the root of Salvia miltiorrhiza Bunge, on tumor invasion and metastasis of human colon carcinoma (CRC) cells.Methods:The effects of tanshinone II-A on invasion and metastasis of CRC cell...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics